The company reports the results of a Phase 2b study for a drug meant to treat pulmonary arterial hypertension.

Novo Nordisk has launched a new late-stage trial for its experimental next-generation obesity drug candidate, CagriSema, as ...

Insmed said on Tuesday that its experimental blood pressure drug met the main and key secondary goals in a mid-stage study, sending shares of the company up 28% in premarket trading.

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

Novo Nordisk has launched a late-stage trial for its obesity drug candidate, CagriSema, aiming to restore market confidence ...

Novo Nordisk initiates a late-stage trial of CagriSema, a next-generation obesity drug, to address potential doubts from ...

Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...

JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...

TuHURA Biosciences said its carcinoma therapy trials can continue now that health regulators have removed the partial clinical hold on the treatment tests.

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety ...

The grants are open to any registered entity (for-profit or non-profit) in good standing with the Kentucky Secretary of State ...